Physiomics (LON:PYC) Stock Price Down 7.4% – Here’s What Happened

Physiomics Plc (LON:PYC)’s stock price fell 7.4% during trading on Thursday. The company traded as low as GBX 0.40 and last traded at GBX 0.44. Approximately 15,677,377 shares changed hands during trading, an increase of 182% from the average session volume of 5,550,020 shares. The stock had previously closed at GBX 0.47.

Physiomics Trading Up 2.6%

The company’s 50 day moving average is GBX 0.50 and its 200-day moving average is GBX 0.49. The stock has a market cap of £1.98 million, a PE ratio of -2.91 and a beta of 1.05.

Physiomics (LON:PYC) last released its earnings results on Tuesday, October 13th. The company reported GBX (0.20) EPS for the quarter. Physiomics had a negative net margin of 74.06% and a negative return on equity of 152.03%. As a group, analysts forecast that Physiomics Plc will post -0.13 EPS for the current year.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.